Tema Oncology ETF
CANCFinancial·Exchange Traded Fund·USA·NASD·Nov 11 • 10:20 AM ET
42.10-0.58 (-1.37%)
2026-11-11 16:21 CET
Market cap
- USD m
Revenue, TTM
- USD m
Net income, TTM
- USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-
P/E
-
Price
CANC against its 20, 50 and 200-day averages2050200
7.3% under 45.41 on 25 Aug 2026. Last 15 sessions, 7.4% high to low
Profile
CANCTema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| No quarterly earnings. | |||||||
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| No annual earnings. | |||||
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| No estimate revisions. | ||||||||
Estimate history
| No estimate history. |
Income statement, annual
No statement data.
Income statement, quarterly
No statement data.
Balance sheet, annual
No statement data.
Cash flow, annual
No statement data.
Balance sheet, quarterly
No statement data.
Cash flow, quarterly
No statement data.
Revenue breakdown
| Revenue split | - |
|---|
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | - | 0.0M | - | 24.47K |
| 2026-10-15 | - | 0.0M | - | 25.72K |
| 2026-09-30 | - | 0.0M | - | 27.38K |
| 2026-09-15 | - | 0.0M | - | 33.80K |
| 2026-08-31 | - | 0.0M | - | 33.18K |
| 2026-08-14 | - | 0.0M | - | 31.78K |
| 2026-07-31 | - | 0.0M | - | 31.69K |
| 2026-07-15 | - | 0.0M | - | 34.13K |
| 2026-06-30 | - | 0.0M | - | 31.33K |
| 2026-06-15 | - | 0.0M | - | 23.09K |
| 2026-05-29 | - | 0.0M | - | 24.15K |
| 2026-05-15 | - | 0.0M | - | 25.17K |
| 2026-04-30 | - | 0.0M | - | 26.02K |
| 2026-04-15 | - | 0.0M | - | 27.08K |
| 2026-03-31 | - | 0.0M | - | 35.93K |
| 2026-03-13 | - | 0.1M | - | 38.81K |
| 2026-02-27 | - | 0.0M | - | 37.50K |
| 2026-02-13 | - | 0.0M | - | 38.56K |
| 2026-01-30 | - | 0.2M | - | 36.66K |
| 2026-01-15 | - | 0.1M | - | 30.98K |
Option chain
expiry 2026-11-11| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| No option chain for this symbol. | ||||||||||
Latest SEC filings
0| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| No filings. | ||||
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 0 | 0 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| THRIVENT FINANCIAL FOR LUTHERANS | 39.87% |
| LPL Financial LLC | 4.22% |
| WJ Wealth Management, LLC | 2.07% |
| HighTower Advisors, LLC | 1.95% |
| JANE STREET GROUP, LLC | 0.59% |
| Stratos Wealth Partners, LTD. | 0.42% |
| Perennial Investment Advisors, LLC | 0.41% |
| UBS Group AG | 0.30% |
| Oder Investment Management, LLC | 0.27% |
| ROYAL BANK OF CANADA | 0.17% |
Funds
| Fund | % owned |
|---|---|
| - | |
OakChart. CANC. Cached 15 minutes.
Some panels did not load: snapshot, ratings, insider, news, lf.